An animal study found that adolescent female rats had higher levels of THC's active metabolite (11-OH-THC) than males after vaping, with corresponding greater behavioral effects at lower doses, while both sexes showed similar hypothermia at high doses.
Researchers studying adolescent cannabis pharmacology, public health professionals considering sex-specific risks of cannabis vaping, and anyone interested in how THC metabolism differs between sexes.
Females: higher active metabolite, greater behavioral effects
What the researchers found
Female adolescent rats had higher 11-OH-THC levels than males in blood and brain after vaped THC exposure. At the low dose (25 mg/ml), females showed greater anxiety-like and exploratory behavioral effects. At the high dose (100 mg/ml), both sexes showed similar hypothermic responses. Sex differences in pharmacokinetics were paralleled by sex differences in behavioral sensitivity.
Why it matters
Most cannabis research uses injection or oral dosing in adult animals. This study provides the first systematic characterization of vaped THC in adolescent rats, a more human-relevant exposure route and age period, revealing important sex differences that could inform public health messaging.
The numbers in context
THC doses: 25 and 100 mg/ml aerosol; 30-minute exposure; blood and brain samples at 5, 30, 60, 120 minutes; females had higher 11-OH-THC; females more behaviorally sensitive at low dose; similar hypothermia at high dose
How the study worked
Pharmacokinetic and pharmacodynamic study in adolescent Wistar rats of both sexes. 30-minute aerosol THC exposure at 25 or 100 mg/ml. LC/MS analysis of THC, 11-OH-THC, and 11-COOH-THC in blood and brain at 5, 30, 60, and 120 minutes. Behavior and temperature measured in separate cohorts.
What this study cannot tell us
Animal study; adolescent rat development does not perfectly parallel human adolescence. Aerosol THC exposure parameters may not match human vaping patterns. Single time point for behavioral testing.
How to read the evidence
Well-designed pharmacokinetic/pharmacodynamic animal study with human-relevant dosing route, but preclinical.
When this study was published
Published in 2021; designed to provide a benchmark for other labs studying vaped THC in adolescent models.
The bigger picture
The higher active metabolite levels in females may explain clinical observations that women report stronger subjective effects from cannabis at similar doses. For adolescents, where brain development is ongoing, these sex differences could mean differential vulnerability to cannabis effects.
Questions still open
- Do these sex differences in metabolite levels explain differential sensitivity to cannabis in human adolescent girls and boys? Are the behavioral effects at low doses predictive of long-term cognitive outcomes? Would different vaping parameters change the sex-difference pattern?
Common questions
Do females respond more strongly to vaped THC?
Why does this matter for teens who vape?
Read the original research
Pharmacokinetic and pharmacodynamic properties of aerosolized ("vaped") THC in adolescent male and female rats.
Psychopharmacology, 238(12), 3595-3605
Citation
Ruiz, C M; Torrens, A; Lallai, V; Castillo, E; Manca, L; Martinez, M X; Justeson, D N; Fowler, C D; Piomelli, D; Mahler, S V. (2021). Pharmacokinetic and pharmacodynamic properties of aerosolized ("vaped") THC in adolescent male and female rats.. Psychopharmacology, 238(12), 3595-3605. https://doi.org/10.1007/s00213-021-05976-8
Explore the wider topic
- How to Talk to Your Teenager About Weed (Without Losing Them)
- My Kid's Friends Smoke Weed: A Parent's Guide
- I Smoke Weed But Don't Want My Kids To: Navigating the Hypocrisy
- Quitting Weed as a Parent: Why It Is the Hardest and Most Important Quit
- Quitting Weed as a Teen or Young Adult
- My Kid Is Smoking Weed: A Parent's Guide